These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5022281)

  • 1. [Apomorphine in opiate withdrawal treatment].
    Hedri A
    Schweiz Rundsch Med Prax; 1972 Apr; 61(15):488-9. PubMed ID: 5022281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apomorphine treatment of withdrawal symptoms in young opiate addicts].
    Gulmann NC; Kaldan B; Kobbernagal F
    Ugeskr Laeger; 1976 Oct; 138(42):2547-50. PubMed ID: 969008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)].
    Amitai M; Dickhaut HH; Hasenknopf P
    Nervenarzt; 1972 Mar; 43(3):157-60. PubMed ID: 5023740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of withdrawal syndrome with apomorphine].
    Ziegler B; Schneider E
    Arzneimittelforschung; 1974 Aug; 24(8):1117-9. PubMed ID: 4479363
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphine withdrawal treatment in 197 admissions for opiates].
    Erikson JH
    Lakartidningen; 1972 May; 69(22):2657-60. PubMed ID: 5068973
    [No Abstract]   [Full Text] [Related]  

  • 6. The short- and long-termed effects of beta-endorphin on the opiate abstinence syndrome in rats.
    Haracz JL; Tseng LF
    Commun Psychopharmacol; 1980; 4(3):219-24. PubMed ID: 6262008
    [No Abstract]   [Full Text] [Related]  

  • 7. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L; Wang D; Li B; Hu M; Zhang P; Li J
    Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of withdrawal symptoms in morphine addicted albino rats.
    Raman G; Ahmed M
    Indian J Exp Biol; 1977 Mar; 15(3):238-9. PubMed ID: 199541
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of reserpine on the morphine abstinence syndrome in mice (author's transl)].
    Kruszewska A; Langwiński R
    Ann Univ Mariae Curie Sklodowska Med; 1979; 34():133-9. PubMed ID: 318053
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Sulpiride as a demorphinization agent.
    De Permentier A
    Med J Aust; 1976 Jan; 1(4):98. PubMed ID: 1263952
    [No Abstract]   [Full Text] [Related]  

  • 12. Narcotic antagonists in the treatment of opiate dependence.
    Fink M; Zaks A; Resnick RB; Freedman AM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine agonist withdrawal syndrome: the apomorphine solution.
    Schlesinger I; Erikh I; Zaaroor M
    Arch Neurol; 2010 Sep; 67(9):1155; author reply 1156. PubMed ID: 20837868
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of alcohol withdrawal symptoms.
    Mayne DG
    Br J Hosp Med; 1982 Jul; 28(1):102. PubMed ID: 7126967
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV; Andreev BV
    Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
    Patkina NA; Evartau EE
    Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP and GABA levels in rat striatum and cerebellum during morphine withdrawal: effect of apomorphine.
    Volicer L; Puri SK; Choma P
    Neuropharmacology; 1977 Nov; 16(11):791-94. PubMed ID: 201885
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice.
    Pourmotabbed A; Rostamian B; Manouchehri G; Pirzadeh-Jahromi G; Sahraei H; Ghoshooni H; Zardooz H; Kamalnegad M
    J Ethnopharmacol; 2004 Dec; 95(2-3):431-5. PubMed ID: 15507371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.